CBIO
NASDAQ · Biotechnology
Crescent Biopharma Inc
$17.55
+0.05 (+0.29%)
Open$17.46
Previous Close$17.50
Day High$17.81
Day Low$17.10
52W High$27.41
52W Low$8.72
Volume—
Avg Volume185.2K
Market Cap487.75M
P/E Ratio—
EPS$-12.33
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+57.6% upside
Current
$17.55
$17.55
Target
$27.66
$27.66
$15.31
$27.66 avg
$30.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 28.34M | 57.99M | 51.60M |
| Net Income | -407,584,942 | 180.8K | 210.8K |
| Profit Margin | -1,438.1% | 0.3% | 0.4% |
| EBITDA | -398,714,577 | 390.2K | 358.0K |
| Free Cash Flow | — | 84.1K | 101.4K |
| Rev Growth | +413.7% | +8.6% | +24.1% |
| Debt/Equity | — | 0.52 | 0.47 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |